Singapore: The Foundry, Lightstone Ventures launch medtech incubator

The Foundry and Lightstone Ventures (LSV) have partnered to launch Foundry SING1, Inc., a medical technology (medtech) incubator that will identify and address unmet clinical needs in Asia.

Foundry SING1 will identify, incubate and deliver innovative medical device solutions for markets in Asia, leveraging Singapore’s burgeoning medtech ecosystem.

Foundry Sing1’s initial investor is Lightstone Singapore, L.P., a Singapore-focused fund founded in 2016 by Lightstone Ventures.

Lightstone Ventures was founded in 2012 by the General Partners of the life science teams at Advanced Technology Ventures (ATV) and Morgenthaler Ventures to invest in early-stage breakthrough medical device and biopharmaceutical companies.

Incepted in 1998, The Foundry aims to rapidly translate concepts into new medtech ventures. In addition to inventing new technologies itself, The Foundry works closely with outside clinicians and inventors with promising ideas.

Over the past 18 years, The Foundry has formed over 15 new companies, including Evalve (acquired by Abbott), Concentric Medical (acquired by Stryker), Ardian (acquired by Medtronic), Twelve (acquired by Medtronic), and incubator Forsight Labs, which has created several successful ophthalmic companies. The Foundry, LLC is located in Menlo Park, California.

Karun D. Naga, a medical device executive with multiple previous successes, has been named President and CEO. Foundry Managing Partners Mark Deem and Hanson Gifford and LSV General Partner Michael Carusi have joined the Company’s Board of Directors.

“While the medtech industry has historically attempted to develop products for Asia by adapting established therapies from Western markets, Foundry SING1 intends to develop solutions primarily focused on clinical needs in Asia with the ultimate goal of implementing these solutions globally,” said Naga.

The Foundry and Lightstone Ventures have a history of collaborating to create new business models as well as novel device technologies. One recent example is the successful incubation of FIRE1, launched in 2013 in Dublin, Ireland, in partnership with Medtronic. The Foundry and LSV hold a shared belief that a global footprint is now an essential element of medical device innovation.

“Leveraging the Singapore medtech ecosystem in partnership with Lightstone Singapore and its Limited Partners, Temasek and EDBI, will give Foundry SING1 a distinct competitive advantage in the region,” said Foundry Managing Partner Mark Deem.

Prior to joining The Foundry as an Entrepreneur in Residence, where he led the formation of Foundry SING1, Karun D. Naga held senior leadership positions at both large and small medical device companies, including Altura Medical, Medtronic and Ardian. He holds an MBA from The University of Pennsylvania Wharton School, a J.D. from the University of Michigan Law School, and a B.S. in Mechanical Engineering from Michigan State University.

Also Read:

Temasek-backed Accuron MedTech leads $11.2m investment into AWAK Tech

Australia: Spacebook & Veromo secure funding; Aussie medtech funding

Russia: New medtech cluster, Addventures leads $3m Series A in MoveSouq, Sistema invests in Luden

Singapore: Trendlines-Braun to operate medtech incubator targeting APAC

China: Infinity Group, Neusoft to kick off $250m fund to grow Israeli medtech firms